| http://www.w3.org/ns/prov#value | - Patients should inform other healthcare professionals prescribing a new medication that they are taking CADUET.Muscle Pain: Advise patients starting therapy with CADUET of the risk of myopathy and to report promptly any unexplained muscle pain, tenderness, or weakness particularly if accompanied by malaise or fever or if these muscle signs or symptoms persist after discontinuing CADUET. The risk o
|
